-
RESTRICT-seq and Epigenetic Dependencies in SCC Resistance
2026-08-21
The bioRxiv preprint introduces RESTRICT-seq as a time-gated CRISPR-screening framework for separating resistance initiation from later resistance maintenance in squamous cell carcinoma models. Its main practical implication is that epigenetic dependencies can be evaluated in relation to treatment timing, although the available reference record does not provide sufficient gene-level or quantitative detail to establish individual targets independently.
-
AG-221: Enasidenib Workflows for IDH2 AML
2026-08-20
AG-221 (Enasidenib) turns IDH2 mutation status into a measurable experimental variable through 2-hydroxyglutarate reduction, viability testing, and differentiation readouts. This workflow extends inhibitor-only studies by probing the CD44-driven metabolic dependency recently identified in IDH-mutant leukemia.
-
Axitinib (AG 013736) VEGFR Assay Workflow
2026-08-20
Axitinib (AG 013736) enables highly selective VEGFR pathway interrogation across endothelial-cell assays, signaling readouts, and tumor models. This workflow shows how to separate pathway inhibition from general growth arrest, improve dose-response reproducibility, and troubleshoot solubility and timing artifacts.
-
Amyloid Beta-peptide (25-35) in AD Assays
2026-08-19
Amyloid Beta-peptide (25-35) is a focused model for dissecting neuronal injury, amyloid aggregation, and microglial signaling. This guide translates recent FLOT1–FOSL2–EphA2 findings into practical assay-design decisions for neurodegenerative disease research.
-
8-Chloroadenosine RNA Research Workflows
2026-08-19
Use 8-Chloroadenosine as a controllable chemical perturbation for transcriptional regulation research, RNA turnover experiments, and cancer-cell phenotyping. Its greatest value emerges when paired with lncRNA knockdown, Actinomycin D decay assays, RIP, and conditioned-medium models rather than used as a stand-alone mechanistic proof.
-
Tubastatin A: HDAC6 Inhibitor Workflows
2026-08-18
Tubastatin A is a selective HDAC6 inhibitor for connecting target engagement with microtubule, inflammatory, survival, and programmed cell-death readouts. Its translational value is illustrated by a porcine cardiac-arrest study, while carefully controlled cell workflows can extend the reagent into cancer biology, neuroprotection, and inflammation research.
-
Anlotinib Hydrochloride: Applied Assay Workflows
2026-08-18
Build reproducible angiogenesis and cancer research assays around Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor that connects receptor phosphorylation with endothelial phenotypes. This practical guide covers dose design, migration and tube-formation workflows, orthogonal validation, comparative interpretation, and troubleshooting.
-
Oleic Acid: Designing Better Lipid Assays
2026-08-17
Oleic Acid (C18:1(9Z)) is more than a lipid supplement: it is a controllable perturbation for studying metabolic signaling, inflammation, and cancer biology. This guide translates recent hepatic ischemia-reperfusion research into practical assay-design decisions for reproducible lipid metabolism research.
-
PD 173074: From FGFR Mechanism to Translation
2026-08-17
PD 173074 is a selective FGFR1 and VEGFR2 research tool that connects kinase mechanism with angiogenesis, tumor biology, stromal signaling, and therapy-resistance studies. This thought-leadership guide explains how to use PD-173074 strategically, interpret its boundaries, and translate pathway data into stronger experimental decisions.
-
Amiloride (MK-870): From Ion Flux to Translation
2026-08-16
Amiloride (MK-870) is more than an epithelial sodium channel blocker: it is a mechanistic probe for separating ion transport, uPAR-linked signaling, and cellular uptake. This thought-leadership guide connects sodium channel research with emerging membrane-trafficking strategies while defining practical validation steps and translational limits.
-
KR-12 Human Antimicrobial Peptide: Bench Guide
2026-08-15
KR-12 is a compact LL-37 fragment for testing membrane disruption, biofilm control, LPS neutralization, and inflammation-linked responses in a single research workflow. This guide connects strain-specific activity benchmarks with formulation, assay design, copper-binding controls, and troubleshooting for more reproducible peptide experiments.
-
Aprotinin and Red Blood Cell Membrane Mechanics
2026-08-14
Aprotinin research is usually framed around fibrinolysis inhibition and cardiovascular surgery blood management. This article develops a complementary framework that connects bovine pancreatic trypsin inhibitor activity with red blood cell membrane mechanics, helping researchers design more discriminating blood-interface assays.
-
Ranolazine Workflows for Cardiac Ischemia Research
2026-08-14
Ranolazine combines late sodium-current modulation with metabolic pathway effects, making it useful for integrated cardiac stress, calcium-handling, and energy-flux experiments. This practical guide covers stock preparation, assay design, liver-cell extensions, controls, and troubleshooting while clearly separating established findings from exploratory applications.
-
CD44 Rewires Metabolism in IDH-Mutant Leukemia
2026-08-13
The reference study identifies CD44-mediated metabolic rewiring as a dependency of IDH-mutant leukemia, linking cell-surface signaling to pentose phosphate pathway activity, NADPH production, and sustained R-2HG synthesis. Its isogenic genetic models and combination experiments support CD44 as a potential partner target for IDH-directed strategies, while also highlighting the need to address resistance and biological heterogeneity.
-
4μ8C for ER Stress Pathway Dissection
2026-08-13
Use 4μ8C to isolate IRE1α RNase signaling from broader ER stress effects in hypoxia, cancer research, and mechanistic UPR studies. This guide pairs a selective chemical probe with the PERK–JAK1–STAT3 findings from nucleus pulposus cells to improve pathway assignment, assay controls, and troubleshooting.